Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load

AIDS

Volumn 26, Issue 14, 2012, Pages 1739-1744

  Karlsson, Ulf ^a   Antonsson, Liselotte ^b   Ljungberg, Bengt ^a   Medstrand, Patrik ^a   Esbjörnsson, Joakim ^b   Jansson, Marianne ^a,c   Gisslen, Magnus ^d  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CCR3; cerebrospinal fluid viral load; CXCR6; HIV 1 R5; late stage disease; subtype C

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR6;

ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; TROPISM; VIRAL TROPISM; VIRUS ISOLATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENOTYPE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, HIV; RECEPTORS, VIRUS; RETROSPECTIVE STUDIES; TROPISM; VIRAL LOAD;

EID: 84866317711     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283560791     Document Type: Article

References (34)

1. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239:586-592. (Pubitemid 18066218)
2. Mothobi NZ, Brew BJ. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 2012; 25:4-9.
3. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain 2006; 129:1872-1883. (Pubitemid 43999418)
4. Karlsson U, Antonsson L, Repits J, Medstrand P, Owman C, Kidd-Ljunggren K, et al. Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates. AIDS Res Hum Retroviruses 2009; 25:1297-1305.
5. Gendelman HE, Meltzer MS. Mononuclear phagocytes and the human immunodeficiency virus. Curr Opin Immunol 1989; 2:414-419. (Pubitemid 20185024)
6. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700. (Pubitemid 29241137)
7. Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, et al. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis 2005; 191:890-898. (Pubitemid 40349804)
8. Soulie C, Tubiana R, Simon A, Lambert-Niclot S, Malet I, Canestri A, et al. Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma. J Acquir Immune Defic Syndr 2009; 51:60-64.
9. Gabuzda D, Wang J. Chemokine receptors and virus entry in the central nervous system. J Neurovirol 1999; 5:643-658. (Pubitemid 30032090)
10. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of micro-glia. Nature 1997; 385:645-649.
11. Agrawal L, Maxwell CR, Peters PJ, Clapham PR, Liu SM, Mackay CR, et al. Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain micro-glia. J Gen Virol 2009; 90:710-722.
12. Soda Y, Shimizu N, Jinno A, Liu HY, Kanbe K, Kitamura T, et al. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem Biophys Res Commun 1999; 258:313-321. (Pubitemid 29287048)
13. Andersson LM, Svennerholm B, Hagberg L, Gisslen M. Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1 isolation. J Med Virol 2000; 62:9-13.
14. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee. Lancet 1997; 349:1086-1092.
15. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 1996; 276:146-154.
16. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, et al. HIV viral load markers in clinical practice. Nat Med 1996; 2:625-629. (Pubitemid 26191942)
17. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997; 71:7478-7487. (Pubitemid 27391688)
18. Esbjornsson J, Mansson F, Martinez-Arias W, Vincic E, Biague AJ, da Silva ZJ, et al. Frequent CXCR4 tropism of HIV-1 subtype A and CRF02-AG during late-stage disease: indication of an evolving epidemic in West Africa. Retrovirology 2010; 7:23.
19. Esbjornsson J, Mild M, Mansson F, Norrgren H, Medstrand P. HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations. PLoS One 2011; 6:e17025.
20. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599. (Pubitemid 47236692)
21. Zwickl DJ. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion [dissertation]. The Univeristy of Texas at Austin; 2006.
22. Martensson UE, Fenyo EM, Olde B, Owman C. Characterization of the human chemerin receptor-ChemR23/CMKLR1-as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains. Virology 2006; 355:6-17. (Pubitemid 44585053)
23. Law NM, Rosenzweig SA. Characterization of the G-protein linked orphan receptor GPRN1/RDC1. Biochem Biophys Res Commun 1994; 201:458-465.
24. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, Mognetti B, Gigout LI, Cheret A, et al. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003; 41:354-370. (Pubitemid 36314149)
25. Noguchi K, Okubo M. Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biol Pharm Bull 2011; 34:1163-1169.
26. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, 2010 revision. http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf, 2010.
27. Price RW, Staprans S. Measuring the 'viral load' in cerebrosp-inal fluid in human immunodeficiency virus infection: window into brain infection? Ann Neurol 1997; 42:675-678. (Pubitemid 27481538)
28. Gorry PR, Churchill M, Crowe SM, Cunningham AL, Gabuzda D. Pathogenesis of macrophage tropic HIV-1. Curr HIV Res 2005; 3:53-60. (Pubitemid 40081285)
29. Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol 2005; 79:1686-1700. (Pubitemid 40459115)
30. Riddick NE, Hermann EA, Loftin LM, Elliott ST, Wey WC, Cervasi B, et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 2010; 6:e1001064.
31. Tscherning-Casper C, Vodros D, Menu E, Aperia K, Fredriksson R, Dolcini G, et al. Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1. J Acquir Immune Defic Syndr 2000; 24:1-9. (Pubitemid 30447800)
32. Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998; 249:367-378. (Pubitemid 28460889)
33. Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, et al. CSF, plasma viral load and HIV associated dementia. J Neurovirol 1998; 4:90-94. (Pubitemid 28081582)
34. Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, et al. Characterization of HIV-Associated Neu-rocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav; 15:1197-1203.